IBM Health Portal: Exclusive Interview with Mr. Haim Nelken, IBM Research

IBMMr. Nelken, in March, IBM announced the next evolution of the patient portal. What is this state-of-the-art IBM Patient Empowerment System?

IBM previewed the IBM Patient Empowerment System at CeBIT in Hanover, Germany and the system demonstrated its standards-based platform which enables patients to integrate and manage their healthcare data for all their medical needs, receive personalized recommendations or alerts for safer medical treatment, and immediately access data from a vast range of sources including: third-party health portals, hospital electronic medical record systems, sensors, home devices for monitoring health conditions, scientific references from PubMed, and more.

The Gacheon University Gil hospital in Korea was one of the first pilot projects of the IBM Patient Empowerment System, could you please share some results?

The project with Gil Hospital is still in the early stages but we are confident that this pilot project will demonstrate increased efficiency and the reduction of costs. The healthcare professionals from Gil hospital are reporting that by giving patients access to information that is relevant to them and easy to understand, they are also improving patient safety during medical treatments.

More so, studies suggest that customer involvement improves satisfaction. Thus, we strongly believe the system will increase patient contentment and will improve user experience.

How do you see the future of the IBM Patient Empowerment System?

Standard based connectivity, adverse drug effects and social medical are the services provided by our system and all of them can be embedded in many systems whether a patient portal, a decision support system, wellness management services and many other services. The increasing adoption of electronic medical records will drive the ongoing need for solutions such as this.

How flexible and customizable is the IBM Patient Empowerment System?

The patient empowerment system is a collection of services bounded within a web portal. The system allows customization in its look and feel and support different presentation to different user groups. For example, patients and doctors can use a single system with different services and views. Additionally, patients may empower others to assist them in managing their records. People who are less comfortable with computers may allow family members to manage their data. We envision, that in the future there will be healthcare and lifestyle consultancy businesses that will work with the patients and thus will be given rights in the patient empowerment system.

The system is SOA based and is built around open healthcare and IT standards. As times goes by, new services and workflows will be developed and integrated, expanding its capabilities as both technologies as well as the ecosystem evolves.

For hospitals interested in implementing the IBM Patient Empowerment System, how do they work with IBM?

IBM works with hospitals worldwide and the IBM Patient Empowerment System is the result of the collaboration among three IBM centers around the world: the IBM Ubiquitous Computing Laboratory in Korea; IBM Research - Haifa, Israel and IBM Research - China.

IBM is also focused on the area of health analytics, which uses sophisticated software to analyze vast amounts of medical data from many different sources at once to quickly help doctors make more informed decisions

We are happy to discuss the project with healthcare organizations interested in learning more. For further information, please simple visit IBM Research, www.research.ibm.com

Could you please underline the contribution of IBM Haifa to the IBM Patient Empowerment System?

We have been focused on three major services that are part of the overall solution, including the integration of clinical data from various sources (such as hospital system and automatic data collection from sensors and devices like scales and blood pressure). One more service that we contributed is the incorporation of pharmacogenetics knowledge for analysis of genetic test results and early notification about potential adverse drug events. Last but not least is the novel service that leverages social and medical networks as a platform for additional interesting and important services.

What "lessons learned" would share to eHealthNews.eu / eHealthServer.com readers from this Research project?

People are almost never indifferent when they see the patient empowerment system. There is always a heated debate - not about the technology, rather about the place of the patient in the healthcare ecosystem, the confidence level we have in patient generated information, the significant influence of the social network in healthcare, etc.

For me, this is what research is about; show people a vision and make it happen. It's those reactions and discussions that help shape our society.

I would also like to emphasize what should be the obvious; collaboration makes things happen. The IBM patient empowerment system is a collaborative effort of research and development in Israel, Korea and China. It brings the skills and capabilities of the labs to create a meaningful worldwide impact.

Thank you!

Related news article:

Most Popular Now

AI Language Models Write Good Doctor…

Generative AI should be able to write usable doctor's letters and thus potentially speed up medical documentation, according to a study by the University Medical Center Freiburg. Around 93% of...

West Yorkshire and Harrogate Hospitals S…

Clinicians working at five of the six trusts in the West Yorkshire Association of Acute Trusts (WYAAT) can access test results from across their pathology network, following a summer roll-out...

When it comes to Emergency Care, ChatGPT…

If ChatGPT were cut loose in the Emergency Department, it might suggest unneeded x-rays and antibiotics for some patients and admit others who didn't require hospital treatment, a new study...

MEDICA 2024 + COMPAMED 2024: Adapted Hal…

11 - 14 November 2024, Düsseldorf, Germany. The final preparations for MEDICA 2024 and COMPAMED 2024 in Düsseldorf have begun. A total of more than 5,500 exhibitors from approximately 70 countries...

AI Drives Development of Cancer Fighting…

University of Houston researchers and their students are developing a new software technology, based on artificial intelligence, for advancing cell-based immunotherapy to treat cancer and other diseases. CellChorus...

AI does Not Necessarily Lead to more Eff…

The use of artificial intelligence (AI) in hospitals and patient care is steadily increasing. Especially in specialist areas with a high proportion of imaging, such as radiology, AI has long...

Revolutionizing Cardiovascular Risk Asse…

A recent position paper in the Asia-Pacific Journal of Ophthalmology explores the transformative potential of artificial intelligence (AI) in ophthalmology. Led by Lama Al-Aswad, Professor of Ophthalmology and Irene Heinz...

HWL 2024 Brings Together a Record Number…

1 - 2 October 2024, Luxembourg. The second edition of Healthcare Week Luxembourg on 1 and 2 October 2024, organised by the Federation of Luxembourg Hospitals (FHL), in partnership with the...

Why the NHS Needs a Transparency Revolut…

Opinion Article by Dr Mark Ratnarajah, NHS paediatrician and UK Managing Director for C2-Ai. Wes Streeting wanted 'no stone left unturned' when he asked Lord Darzi to examine the current state...

Why the NHS is Seeking to Make Media Ser…

Opinion Article by Dean Moody, Healthcare Services Director, Airwave Healthcare. Tim Kelsey and Martha Lane Fox called for WiFi to be made available free of charge throughout the NHS back in...

Great Start for Ideas and Innovations: D…

8 - 10 April 2025, Berlin, Germany. From 15 October to 15 November 2024, the DMEA invites experts from business, science, politics and practice to actively participate in shaping the congress...

An AI-Powered Pipeline for Personalized …

Ludwig Cancer Research scientists have developed a full, start-to-finish computational pipeline that integrates multiple molecular and genetic analyses of tumors and the specific molecular targets of T cells and harnesses...